Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Chinese Patent Office
Teva
Cipla
Covington
Boehringer Ingelheim
UBS
Healthtrust

Generated: April 25, 2018

DrugPatentWatch Database Preview

DTIC-DOME Drug Profile

« Back to Dashboard

When do Dtic-dome patents expire, and when can generic versions of Dtic-dome launch?

Dtic-dome is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in DTIC-DOME is dacarbazine. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dacarbazine profile page.
Drug patent expirations by year for DTIC-DOME
Medical Subject Heading (MeSH) Categories for DTIC-DOME
Synonyms for DTIC-DOME
(5E)-5-(dimethylaminohydrazinylidene)-4-imidazolecarboxamide
(5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
(5E)-5-(dimethylaminohydrazono)imidazole-4-carboxamide
(5Z)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
(5Z)-5-(dimethylaminohydrazono)imidazole-4-carboxamide
(Dimethyltriazeno)imidazolecarboxamide
1H-Imidazole-4-carboxamide, 5- (3,4-dimethyl-1-triazenyl)-
1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-
1H-Imidazole-4-carboxamide,3-dimethyl-1-triazenyl)-
342D034
37626-23-6
4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide
4-(3,3-Dimethyltriaz-1-en-1-yl)-1H-imidazole-5-carboxamide
4-(3,3-Dimethyltriazeno)imidazole-5-carboxamide
4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide
4-(Dimethyltriazeno)imidazole-5-c arboxamide
4-(Dimethyltriazeno)imidazole-5-carboxamide
4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide
4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide
4-[(1E)-3,3-Dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide
4-[(E)-dimethylaminoazo]-1H-imidazole-5-carboxamide
4-[3,3-dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide
4(5)-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide
4(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide
4342-03-4
5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide
5-(3,3-Dimethyl-1-Triazeno1-Imidazole-4-Carboxamid
5-(3,3-Dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide
5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
5-(3,3-Dimethyltri azeno)imidazole-4-carboxamide
5-(3,3-dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide
5-(3,3-Dimethyltriazeno)-imidazole-4-carbamide
5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide
5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
5-(dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide
5-(Dimethyltriazeno)-4-imidazolecarboxamide
5-(Dimethyltriazeno)imidazole-4-carboxamide
5-(Dimethyltriazeno)imidazole-4-carboximide
5-[(dimethylamino)diazenyl]imidazole-4-carboxamide
5-[(E)-dimethylaminodiazenyl]-1H-imidazole-4-carboxamide
5-[3,3-Dimethyl-1-triazenyl]imidazole-4-carboxamide
5(or 4)-(dimethyltriazeno)imidazol e-4(or 5)-carboxamide
5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide
7GR28W0FJI
A826278
AB2000013
AC1NS01W
AC1NS4BN
AI3-52825
AK326233
AKOS005220502
AKOS015850745
AKOS026750028
AKOS027327595
API0002201
BDBM233149
Biocarbazin
Biocarbazine
Biocarbazine R
BPBio1_000428
BRD-K35520305-001-07-8
BSPBio_000388
BSPBio_002091
C06936
C6H10N6O
Carboxamide (TN)
Carboxamide, 5-(3,3-dimethyl-1-triazeno)imidazole-4-
Carboxamide, Dimethyl Imidazole
Carboxamide,3-dimethyl-1-triazeno)imidazole-4-
CAS-891986
CCG-220574
CCG-35381
CCG-36068
CCG-40272
CCRIS 190
CD0135
CHEBI:4305
CHEBI:94587
CHEMBL1355683
CHEMBL1574179
CHEMBL476
CS-1772
D00288
D0Y7ZU
D3634
Dacarbazin
dacarbazina
dacarbazine
Dacarbazine (DTIC-Dome)
Dacarbazine (JAN/USP/INN)
Dacarbazine [USAN:INN:BAN:JAN]
Dacarbazine, antineoplastic purine analog
Dacarbazine, European Pharmacopoeia (EP) Reference Standard
Dacarbazine, United States Pharmacopeia (USP) Reference Standard
Dacarbazino
Dacarbazino [INN-Spanish]
Dacarbazinum
Dacarbazinum [INN-Latin]
Dacatic
DB00851
Decarbazine
Deticene
Di-me-triazenoimidazolecarboxamide
Di-methyl-triazenoimidazolecarboxamide
DIC (TN)
Dimethyl Imidazole Carboxamide
Dimethyl Triazeno Imidazole Carboxamide
Dimethyltriazenoimidazolecarboxamide
DivK1c_000326
DTCI
DTIC
DTIC (TN)
DTIC Dome
Dtic-Dome (TN)
DTIC, DTIC-Dome, Dacarbazine
DTIC;DTIC-Dome
DTICDome
DTIE
EINECS 224-396-1
FCH4071365
FDKXTQMXEQVLRF-ZHACJKMWSA-N
GTPL9075
H539
HE001892
HE1150000
HMS1569D10
HMS2090A20
HMS2091I20
HMS2096D10
HMS2231L23
HMS501A08
HSDB 3219
HY-B0078
I06-2280
I14-1659
ICDMT
ICDT
IDI1_000326
Imidazole (TN)
Imidazole Carboxamide, Dimethyl
Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-
Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-
Imidazole-4-carboxamide,3-dimethyl-1-triazeno)-
Imidazole-4(or 5)-carboxamide, 5(or 4)-(3,3-dimethyl-1-triazeno)-
Imidazole-4(or 5)-carboxamide,3-dimethyl-1-triazeno)-
J10199
KB-49549
KBio1_000326
KBio2_001364
KBio2_003932
KBio2_006500
KBio3_001311
KBioGR_000896
KBioSS_001364
KS-5186
LS-119
M-2571
MCULE-7282678858
MFCD00057167
MLS001332543
MLS001332544
MolPort-003-666-153
MolPort-003-846-120
MolPort-044-723-991
NCGC00016986-01
NCGC00091861-01
NCGC00091861-02
NCGC00091861-03
NCGC00091861-04
NCGC00091861-05
NCGC00188955-01
NCI-C04717
NCI60_004053
NCIMech_000261
NINDS_000326
NPFAPI-05
NSC 45388
NSC-45388
NSC-759610
NSC45388
NSC759610
Pharmakon1600-01500218
Prestwick_904
Prestwick0_000574
Prestwick1_000574
Prestwick2_000574
Prestwick3_000574
s1221
SBI-0051328.P003
SC-17180
SCHEMBL1014331
SCHEMBL12591753
SCHEMBL5560
SCHEMBL5561
SMP2_000251
SMR000857131
SPBio_001075
SPBio_002607
Spectrum_000884
SPECTRUM1500218
Spectrum2_001148
Spectrum3_000366
Spectrum4_000308
Spectrum5_000823
SR-05000001598
SR-05000001598-3
ST51014976
UNII-7GR28W0FJI
W-106228
WLN: T5M CNJ DVZ ENUNN1&1
ZINC109564502
ZINC18099447

US Patents and Regulatory Information for DTIC-DOME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare DTIC-DOME dacarbazine INJECTABLE;INJECTION 017575-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare DTIC-DOME dacarbazine INJECTABLE;INJECTION 017575-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
Julphar
Chubb
Accenture
US Department of Justice
Cerilliant
Chinese Patent Office
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.